{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:43:47Z","timestamp":1754153027958,"version":"3.41.2"},"reference-count":32,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Children who require mechanical ventilation (MV) often receive neuropharmacological agents for analgosedation, although the US Food &amp; Drug Administration has warned that some agents may be neurotoxic in young children. We have previously reported concurrent increases in neuropharmacological agent prescription and usage of rehabilitative services in children with bronchiolitis who received MV. We now aim to assess for similar trends in a more heterogeneous population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>With institutional review board approval, we queried the Pediatric Health Information Systems (PHIS) database for children aged younger than 36\u00a0months with receipt of MV for at least 2\u00a0days between 2006 and 2020 and (nonneonatal) intensive care unit admission. Surgical patients were identified by operating room charges and were excluded. Data extracted included demographics, neuropharmacological agents prescribed for at least 2\u00a0days, billing for services that evaluate and treat neurological morbidity (eg, physical therapy, swallow evaluation), and clinical outcomes. Temporal trends were analyzed using simple linear regression, Kruskal-Wallis rank-sum testing was used to compare years, and P\u2009&amp;lt;\u2009.01 defined statistical significance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Among 52\u2009633 patients, the median (IQR) age was 0.4 (0.1\u20131.2) years, and 56.9% were male. The proportion of children prescribed at least 5 different drugs\/drug classes increased significantly from 29.8% in 2006 to 42.4% in 2020. Drugs with significantly increased prescription from 2006 to 2020, respectively, included antipsychotics (1.2% to 6.1%), clonidine (2.4% to 22.1%), dexmedetomidine (4.2% to 57.1%), ketamine (7.9% to 17.0%), methadone (18.5% to 20.7%), and propofol (4.1% to 9.7%). Drugs with significantly decreased prescription included chloral hydrate (18.8% to 3.3%), midazolam (71.6% to 51.1%), and pentobarbital (5.8% to 1.7%). Usage of at least 2 morbidity-related services significantly increased (24.5% in 2006 to 60.6% in 2020). Mortality decreased significantly (12.5% in 2006 to 10.2% in 2020).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Among young, nonsurgical pediatric intensive care unit patients who received MV, there have been concurrent increases in prescription of several neuropharmacological agents and services related to neurologic morbidity. Prospective studies are needed to evaluate the causes and effects of these changes in practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2024-007960","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T20:02:20Z","timestamp":1745870540000},"page":"e186-e193","source":"Crossref","is-referenced-by-count":0,"title":["Trends in Neuropharmacological Medications Over Time in Mechanically Ventilated Nonsurgical Patients Aged Younger Than 3\u00a0Years"],"prefix":"10.1542","volume":"15","author":[{"given":"Allison M.","family":"Blatz","sequence":"first","affiliation":[{"name":"1Center for Biostatistics and Clinical Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"2Department of Pediatrics, Division of Pediatric Critical Care Medicine, UH Rainbow Babies & Children\u2019s Hospital, Cleveland, Ohio"},{"name":"3Department of Pediatrics, Division of Critical Care Medicine, Nemours Children\u2019s Health\/A.I. duPont Hospital for Children, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanne","family":"Wilson-Costello","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Division of Neonatology, UH Rainbow Babies & Children\u2019s Hospital, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre T.","family":"Rotta","sequence":"additional","affiliation":[{"name":"5Department of Pediatrics, Division of Pediatric Critical Care Medicine, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Pradhan","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Division of Pediatric Critical Care Medicine, UH Rainbow Babies & Children\u2019s Hospital, Cleveland, Ohio"},{"name":"6The Hospital for Sick Children, The Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Shein","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Division of Pediatric Critical Care Medicine, UH Rainbow Babies & Children\u2019s Hospital, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"2","key":"2025072210024928700_r1","doi-asserted-by":"crossref","first-page":"e2037227","DOI":"10.1001\/jamanetworkopen.2020.37227","article-title":"Trends in US pediatric hospital admissions in 2020 compared with the decade before the COVID-19 pandemic","volume":"4","author":"Pelletier","year":"2021","journal-title":"JAMA Netw Open."},{"article-title":"SCCM","year":"2024","author":"Critical Care Statistics","key":"2025072210024928700_r2"},{"issue":"6","key":"2025072210024928700_r3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bja.2017.11.107","article-title":"Systematic review of the neurocognitive outcomes used in studies of paediatric anaesthesia neurotoxicity","volume":"120","author":"Clausen","year":"2018","journal-title":"Br J Anaesth."},{"issue":"1","key":"2025072210024928700_r4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.anclin.2013.10.003","article-title":"Anesthetic neurotoxicity","volume":"32","author":"Lin","year":"2014","journal-title":"Anesthesiol Clin."},{"issue":"5","key":"2025072210024928700_r5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.pcl.2017.06.013","article-title":"Sedation analgesia and neuromuscular blockade in pediatric critical care: overview and current landscape","volume":"64","author":"Zuppa","year":"2017","journal-title":"Pediatr Clin North Am."},{"issue":"3","key":"2025072210024928700_r6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/pan.12257","article-title":"Neurotoxicity of sedative and analgesia drugs in young infants with congenital heart disease: 4-year follow-up","volume":"24","author":"Garcia Guerra","year":"2014","journal-title":"Paediatr Anaesth."},{"issue":"4","key":"2025072210024928700_r7","first-page":"e0105","article-title":"Potential neurodevelopmental effects of pediatric intensive care sedation and analgesia: repetitive benzodiazepine and opioid exposure alters expression of glial and synaptic proteins in juvenile rats","volume":"2","author":"Iqbal O\u2019Meara","year":"2020","journal-title":"Crit Care Explor."},{"issue":"21","key":"2025072210024928700_r8","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1001\/jama.2016.6967","article-title":"al. et. Association between a single general anesthesia exposure before age 36\u00a0months and neurocognitive outcomes in later childhood","volume":"315","author":"Sun","year":"2016","journal-title":"JAMA."},{"article-title":"FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women","year":"2016","author":"FDA Drug Safety Communication","key":"2025072210024928700_r9"},{"issue":"12","key":"2025072210024928700_r10","doi-asserted-by":"crossref","first-page":"e606","DOI":"10.1097\/PCC.0000000000001351","article-title":"Temporal changes in prescription of neuropharmacologic drugs and utilization of resources related to neurologic morbidity in mechanically ventilated children with bronchiolitis","volume":"18","author":"Shein","year":"2017","journal-title":"Pediatr Crit Care Med."},{"issue":"4","key":"2025072210024928700_r11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1542\/peds.2009-3266","article-title":"Children with complex chronic conditions in inpatient hospital settings in the United States","volume":"126","author":"Simon","year":"2010","journal-title":"Pediatrics."},{"issue":"1","key":"2025072210024928700_r12","first-page":"60","article-title":"Mechanical ventilation for children","volume":"22","author":"Conti","year":"2016","journal-title":"Curr Opin Crit Care."},{"issue":"7","key":"2025072210024928700_r13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","article-title":"PELOD-2: an update of the PEdiatric logistic organ dysfunction score","volume":"41","author":"Leteurtre","year":"2013","journal-title":"Crit Care Med."},{"issue":"7","key":"2025072210024928700_r14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PCC.0b013e31829760cf","article-title":"Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care","volume":"14","author":"Straney","year":"2013","journal-title":"Pediatr Crit Care Med."},{"issue":"suppl 3","key":"2025072210024928700_r15","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1542\/peds.2017-1284E","article-title":"Status complexicus? The emergence of pediatric complex care","volume":"141","author":"Cohen","year":"2018","journal-title":"Pediatrics."},{"issue":"4","key":"2025072210024928700_r16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2014.18399","article-title":"Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial","volume":"313","author":"Curley","year":"2015","journal-title":"JAMA."},{"issue":"1","key":"2025072210024928700_r17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/EJA.0b013e32833e266d","article-title":"Dexmedetomidine: new insights","volume":"28","author":"Mantz","year":"2011","journal-title":"Eur J Anaesthesiol."},{"issue":"4","key":"2025072210024928700_r18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jcrc.2015.04.005","article-title":"Pharmacologic prevention and treatment of delirium in intensive care patients: a systematic review","volume":"30","author":"Serafim","year":"2015","journal-title":"J Crit Care."},{"issue":"4","key":"2025072210024928700_r19","first-page":"327","article-title":"Evaluation of an enteral clonidine taper following prolonged dexmedetomidine exposure in critically ill children","volume":"11","author":"Crabtree","year":"2021","journal-title":"J Pediatr Intensive Care."},{"issue":"2","key":"2025072210024928700_r20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.PCC.0000257100.31779.41","article-title":"Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology","volume":"8","author":"Tobias","year":"2007","journal-title":"Pediatr Crit Care Med."},{"issue":"1","key":"2025072210024928700_r21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4088\/JCP.v68n0102","article-title":"Antipsychotics in the treatment of delirium: a systematic review","volume":"68","author":"Seitz","year":"2007","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"2025072210024928700_r22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13054-022-04077-y","article-title":"The future of intensive care: delirium should no longer be an issue","volume":"26","author":"Kotfis","year":"2022","journal-title":"Crit Care."},{"issue":"3","key":"2025072210024928700_r23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ccc.2023.01.004","article-title":"Thinking clearly: the history of brain dysfunction in critical illness","volume":"39","author":"Rengel","year":"2023","journal-title":"Crit Care Clin."},{"key":"2025072210024928700_r24","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2022-324939","article-title":"Chloral hydrate \u2013 use as a sedative in paediatric settings","author":"Wyness","year":"2023","journal-title":"Archives of Disease in Childhood - Education and Practice."},{"key":"2025072210024928700_r25","doi-asserted-by":"crossref","first-page":"1111528","DOI":"10.3389\/fphar.2023.1111528","article-title":"Retrospective observational study of chloral hydrate use in mechanically-ventilated pediatric intensive care unit (PICU) patients 2012\u20132017","volume":"14","author":"Ettinger","year":"2023","journal-title":"Front Pharmacol."},{"issue":"3","key":"2025072210024928700_r26","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1097\/PCC.0000000000001070","article-title":"Long-term function after pediatric critical illness: results from the survivor outcomes study","volume":"18","author":"Pinto","year":"2017","journal-title":"Pediatr Crit Care Med."},{"issue":"5","key":"2025072210024928700_r27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CCM.0000000000004291","article-title":"Physical rehabilitation in critically ill children: a multicenter point prevalence study in the United States","volume":"48","author":"Kudchadkar","year":"2020","journal-title":"Crit Care Med."},{"issue":"7","key":"2025072210024928700_r28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00134-015-3780-7","article-title":"Health-related quality of life following pediatric critical illness","volume":"41","author":"Aspesberro","year":"2015","journal-title":"Intensive Care Med."},{"issue":"6","key":"2025072210024928700_r29","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1542\/peds.107.6.e99","article-title":"Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services","volume":"107","author":"Feudtner","year":"2001","journal-title":"Pediatrics."},{"issue":"7","key":"2025072210024928700_r30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/PCC.0000000000002956","article-title":"Epidemiology of pediatric critical care admissions in 43 United States children\u2019s hospitals, 2014\u20132019","volume":"23","author":"Heneghan","year":"2022","journal-title":"Pediatr Crit Care Med."},{"issue":"9","key":"2025072210024928700_r31","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/PCC.0000000000000254","article-title":"Pediatric severe sepsis: current trends and outcomes from the Pediatric Health Information Systems database","volume":"15","author":"Ruth","year":"2014","journal-title":"Pediatr Crit Care Med."},{"issue":"3_MeetingAbstract","key":"2025072210024928700_r32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.147.3MA6.567","article-title":"How generalizable is freestanding children\u2019s hospital data such as PHIS (Pediatric Health Information System)?","volume":"147","author":"Harrington","year":"2021","journal-title":"Pediatrics."}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/15\/5\/e186\/1801995\/hosppeds.2024007960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/15\/5\/e186\/1801995\/hosppeds.2024007960.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T14:20:08Z","timestamp":1753194008000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/15\/5\/e186\/201692\/Trends-in-Neuropharmacological-Medications-Over"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,29]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2024-007960","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"type":"print","value":"2154-1663"},{"type":"electronic","value":"2154-1671"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}